Brenda Ginos

1.4k total citations
29 papers, 212 citations indexed

About

Brenda Ginos is a scholar working on Oncology, Economics and Econometrics and Surgery. According to data from OpenAlex, Brenda Ginos has authored 29 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Economics and Econometrics and 6 papers in Surgery. Recurrent topics in Brenda Ginos's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Cancer survivorship and care (6 papers) and Esophageal Cancer Research and Treatment (4 papers). Brenda Ginos is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Cancer survivorship and care (6 papers) and Esophageal Cancer Research and Treatment (4 papers). Brenda Ginos collaborates with scholars based in United States and Malaysia. Brenda Ginos's co-authors include Amylou C. Dueck, Ethan Basch, Deborah Schrag, Lauren J. Rogak, Gina L. Mazza, Tatjana Kolevska, Sandra A. Mitchell, Harvey J. Mamon, Andrea Denicoff and Gita Thanarajasingam and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Brenda Ginos

27 papers receiving 212 citations

Peers

Countries citing papers authored by Brenda Ginos

Since Specialization

Citations

This map shows the geographic impact of Brenda Ginos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Ginos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Ginos more than expected).

Fields of papers citing papers by Brenda Ginos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Ginos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Ginos. The network helps show where Brenda Ginos may publish in the future.

Co-authorship network of co-authors of Brenda Ginos

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Ginos. A scholar is included among the top collaborators of Brenda Ginos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Ginos. Brenda Ginos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Methods for implementing and reporting the Patient‐Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient‐reported adverse events in cancer clinical trials 2025 ·Cancer ·Amylou C. Dueck, Gita Thanarajasingam, (unknown), Gina L. Mazza, Blake Langlais, Brie N. Noble, Brenda Ginos, Carolyn Mead‐Harvey, (unknown), Minji K. Lee, Allison M. Deal, (unknown), Ethan Basch	0
2	Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden 2025 ·Cancers ·Minji K. Lee, Sandra A. Mitchell, Ethan Basch, Allison M. Deal, Blake Langlais, Gita Thanarajasingam, Brenda Ginos, (unknown), Tito R. Mendoza, Antonia V. Bennett, Brie N. Noble, Gina L. Mazza, Amylou C. Dueck	0
3	Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials 2025 ·Contemporary Clinical Trials Communications ·(unknown), (unknown), Ethan Basch, Gina L. Mazza, Minji K. Lee, (unknown), Brenda Ginos, Blake Langlais, Brie N. Noble, Allison M. Deal, (unknown), Gita Thanarajasingam, Amylou C. Dueck	2
4	Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) 2024 ·Quality of Life Research ·Minji K. Lee, Sandra A. Mitchell, Ethan Basch, Gina L. Mazza, Blake Langlais, Gita Thanarajasingam, Brenda Ginos, Lauren J. Rogak, (unknown), Jennifer Jansen, Allison M. Deal, Philip Carr, Victoria Blinder, Mattias Jönsson, Gita N. Mody, Tito R. Mendoza, Antonia V. Bennett, Deborah Schrag, Amylou C. Dueck	2
5	Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39) 2024 ·Quality of Life Research ·Gina L. Mazza, Amylou C. Dueck, Brenda Ginos, Jennifer Jansen, Allison M. Deal, Philip Carr, Victoria Blinder, Gita Thanarajasingam, Mattias Jönsson, Minji K. Lee, Lauren J. Rogak, Gita N. Mody, Deborah Schrag, Ethan Basch	9
6	Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE ^® ) in a diverse cancer sample 2024 ·Clinical Trials ·Carolyn Mead‐Harvey, Ethan Basch, (unknown), Blake Langlais, Gita Thanarajasingam, Brenda Ginos, Minji K. Lee, (unknown), Sandra A. Mitchell, Lori M. Minasian, Tito R. Mendoza, Antonia V. Bennett, Deborah Schrag, Amylou C. Dueck, Gina L. Mazza	1
7	Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period 2023 ·Quality of Life Research ·Minji K. Lee, Ethan Basch, Sandra A. Mitchell, Lori M. Minasian, Blake Langlais, Gita Thanarajasingam, Brenda Ginos, Lauren J. Rogak, Tito R. Mendoza, Antonia V. Bennett, Deborah Schrag, Gina L. Mazza, Amylou C. Dueck	8
8	Systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma. 2023 ·Journal of Clinical Oncology ·(unknown), Joselle Cook, Kah-Whye Peng, Susan Geyer, Brenda Ginos, Lianwen Zhang, (unknown), Thomas E. Witzig, Javier Muñoz, Stephen M. Broski, Stephen J. Russell, Martha Q. Lacy	1
9	Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Katharine A. Price, Kathryn M. Van Abel, Eric J. Moore, Samir H. Patel, Michael L. Hinni, Ashish V. Chintakuntlawar, Darlene E. Graner, M.A. Neben-Wittich, Yolanda I. Garces, Daniel L. Price, Jeffrey R. Janus, Nathan R. Foster, Brenda Ginos, Robert L. Foote, J. Daniel	6
10	A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39). 2022 ·Journal of Clinical Oncology ·Victoria Blinder, Allison M. Deal, Brenda Ginos, Jennifer Jansen, Amylou C. Dueck, Gina L. Mazza, Sydney Henson, Philip Carr, Lauren J. Rogak, Anna Weiss, (unknown), Patricia A. Spears, Francesca Gany, Deborah Schrag, Ethan Basch	2
11	Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39) 2021 ·Lung Cancer ·Gita N. Mody, Angela M. Stover, Mian Wang, Bellinda L. King‐Kallimanis, Jennifer Jansen, Sydney Henson, Arlene E. Chung, Mattias Jönsson, Antonia V. Bennett, Angela B. Smith, William A. Wood, (unknown), Brenda Ginos, Amylou C. Dueck, Deborah Schrag, Ethan Basch	18
12	Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]) 2021 ·European Journal of Cancer ·Harry H. Yoon, Fang‐Shu Ou, Gamini S. Soori, Qian Shi, Dennis A. Wigle, Robert P. Sticca, Robert C. Miller, James L. Leenstra, Patrick J. Peller, Brenda Ginos, Erica N. Heying, Tsung‐Teh Wu, (unknown), Stephen Ko, Bassam Mattar, Daniel A. Nikcevich, Robert J. Behrens, Maged Khalil, George P. Kim, Steven R. Alberts	13
13	Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 2021 ·Quality of Life Research ·Gina L. Mazza, M. Petersen, Brenda Ginos, Blake Langlais, (unknown), Mrinal M. Gounder, Michelle R. Mahoney, (unknown), Gary K. Schwartz, Lauren J. Rogak, Gita Thanarajasingam, Ethan Basch, Amylou C. Dueck	3
14	Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data 2021 ·Journal of Pain and Symptom Management ·Blake Langlais, Gina L. Mazza, Gita Thanarajasingam, Lauren J. Rogak, Brenda Ginos, (unknown), Howard I. Scher, Gisela Schwab, Patricia A. Ganz, Ethan Basch, Amylou C. Dueck	15
15	A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Leslie Padrnos, Brenda Ernst, Amylou C. Dueck, Heidi Kosiorek, Brenda Ginos, (unknown), Patrick B. Johnston, Thomas M. Habermann, José F. Leis, Joseph Mıkhael, Grzegorz S. Nowakowski, Joseph P. Colgan, Luis F. Porrata, Stephen M. Ansell, Thomas E. Witzig, Craig B. Reeder	6
16	Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048 2018 ·Journal of Clinical Oncology ·Ethan Basch, Amylou C. Dueck, Lauren J. Rogak, Sandra A. Mitchell, Lori M. Minasian, Andrea Denicoff, (unknown), Mary Shaw, (unknown), Qian Shi, Brenda Ginos, Garth D. Nelson, Jeffrey P. Meyers, George J. Chang, Harvey J. Mamon, Martin R. Weiser, Tatjana Kolevska, Bryce B. Reeve, Deborah Watkins Bruner, Deborah Schrag	53
17	Predictors of Progression in Barrett’s Esophagus with Low-Grade Dysplasia: Results from a Multicenter Prospective BE Registry 2017 ·The American Journal of Gastroenterology ·Rajesh Krishnamoorthi, Jason S. Lewis, Murli Krishna, (unknown), Michele L. Johnson, Ross Dierkhising, Brenda Ginos, Kenneth K. Wang, Herbert C. Wolfsen, David E. Fleischer, Francisco C. Ramirez, Navtej Buttar, David A. Katzka, Prasad G. Iyer	19
18	Impact of Weight on Symptom Burden Outcomes in Myeloproliferative Neoplasm Patients Participating in an Online Yoga Intervention 2016 ·Blood ·Ryan Eckert, Jennifer Huberty, Krisstina Gowin, Brenda Ginos, Heidi Kosiorek, Amylou C. Dueck, Ruben A. Mesa	4
19	Online-Streamed Yoga As a Non-Pharmacologic Symptom Management Approach in Myeloproliferative Neoplasms 2016 ·Blood ·Jennifer Huberty, Ryan Eckert, Krisstina Gowin, Brenda Ginos, Heidi Kosiorek, Amylou C. Dueck, Ruben A. Mesa	5
20	Impact of Histology Confirmation by GI Pathologist Panel on Progression Rates in Barrettʼs Esophagus With Low-Grade Dysplasia: Results From a Multicenter Prospective BE Registry 2015 ·The American Journal of Gastroenterology ·Rajesh Krishnamoorthi, Murli Krishna, (unknown), (unknown), Michele L. Johnson, Ross Dierkhising, Brenda Ginos, Kenneth K. Wang, Yvonne Romero, David A. Katzka, Navtej Buttar, Prasad G. Iyer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact